Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)

Bibliographic Details
Main Authors:	Carballo, S, Blair, E, Watkins, H
Format:	Conference item
Published:	2005

Similar Items

Novel mutations in cardiac MYBPC3 causing early onset malignant hypertrophic cardiomyopathy
by: Carballo, S, et al.
Published: (2005)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
by: Carballo, S, et al.
Published: (2005)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
by: Carballo, S, et al.
Published: (2003)

Autosomal dominant HCM and DCM phenotype caused by a novel mutation in phospholamban
by: Carballo, S, et al.
Published: (2004)

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
by: Marilena Melas, et al.
Published: (2022-12-01)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
by: Neubauer, S, et al.
Published: (2019)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry
by: Neubauer, S, et al.
Published: (2019)

Delineating the role of adenosine monophosphate (AMP)-activated protein kinase (AMP) gamma 2 subunit in hypertrophic cardiomyopathy (HCM)
by: Grignani, R, et al.
Published: (2005)

A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance
by: Carballo, S, et al.
Published: (2004)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
by: Dirceu Rodrigues Almeida
Published: (2019-04-01)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death.
by: Dass, S, et al.
Published: (2012)

METABOLIC ALTERATION IN HYPERTROPHIC CARDIOMYOPATHY (METAL-HCM STUDY): RANDOMISED DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OF PERHEXILINE THERAPY IN PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: Abozguia, K, et al.
Published: (2010)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
by: Dawson Dana, et al.
Published: (2009-01-01)

Evidence for haploinsufficiency as the mechanism of action of MyBP-C mutations that cause HCM
by: Carballo, S, et al.
Published: (2008)

Autosomal dominant familial dilated cardiomyopathy caused by a novel mutation in phospholamban
by: Carballo, S, et al.
Published: (2004)

Global extracellular volume (ECVglobal) in HCM - the "next generation" test for risk in hypertrophic cardiomyopathy?
by: Sado Daniel, et al.
Published: (2013-01-01)

Venous dysfunction in obstructive hypertrophic cardiomyopathies: Results from the “HCM-Vein” pilot study
by: Patricia Réant, et al.
Published: (2023-04-01)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
by: Abdulrazzak, H, et al.
Published: (2001)

Complement system specifically C5a receptor, inflammation and hypertrophic cardiomyopathy (HCM) in cats
by: Khor, Kuan Hua
Published: (2015)

Interaction analyses elucidate the pathophysiology of HCM-causing missense mutations in cardiac myosin binding protein-C.
by: Moolman-Smook, J, et al.
Published: (2001)

Familial dilated cardiomyopathy associated with congenital defects in the setting of a novel VCL mutation (Lys815Arg) in conjunction with a known MYPBC3 variant
by: Quinn S. Wells, et al.
Published: (2011-08-01)

Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.
by: Burton, D, et al.
Published: (2002)

Two mutations in human cardiac troponin I known to cause hypertrophic cardiomyopathy have different effects on cardiac muscle contraction
by: Burton, D, et al.
Published: (2000)

Clinical Application of the HCM-AF Risk Score in the Prediction of Clinical Outcomes of Polish Patients with Hypertrophic Cardiomyopathy
by: Maria Stec, et al.
Published: (2023-07-01)

Double mutations in CIS can confound genotype-phenotype correlations in hypertrophic cardiomyopathy
by: Blair, E, et al.
Published: (2000)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2001)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
by: Hudsmith, L, et al.
Published: (2006)

Classifying Cardiac Actin Mutations Associated With Hypertrophic Cardiomyopathy
by: Evan A. Despond, et al.
Published: (2018-04-01)

The effect of HCM mutations in troponin T and troponin I on the calcium binding of human cardiac troponin
by: Redwood, C, et al.
Published: (2001)

Effects of hypertrophic cardiomyopathy mutations in troponin I on contractility of skinned cardiac muscle fibres
by: Burton, D, et al.
Published: (2002)

Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency.
by: Marston, S, et al.
Published: (2009)

Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.
by: Elliott, K, et al.
Published: (2000)

Direct evidence in man for haploinsufficiency as the mechanism of action of myosin-binding protein C mutations that cause hypertrophic cardiomyopathy
by: Carballo, S, et al.
Published: (2008)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
by: Robinson, P, et al.
Published: (2002)

Linked genetic modifiers in hypertrophic cardiomyopathy
by: Ektisham, J, et al.
Published: (2004)

A revised method of troponin exchange in permeabilised cardiac trabeculae using vanadate: functional consequences of a HCM-causing mutation in troponin I.
by: Preston, L, et al.
Published: (2006)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2003)

How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
by: Marston, S, et al.
Published: (2012)

Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy.
by: Geier, C, et al.
Published: (2008)

Functional analysis of hypertrophic cardiomyopathy missense mutations in the light meromyosin region of beta myosin heavy chain
by: Redwood, C, et al.
Published: (2003)